Evaluation of Pregabalin's Abuse Liability and Its Effects on Benzodiazepine Withdrawal Symptoms in Inpatients Undergoing Medically Assisted Benzodiazepine Withdrawal
Phase of Trial: Phase IV
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Pregabalin (Primary)
- Indications Substance-related disorders
- Focus Therapeutic Use
- 21 Mar 2016 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 29 Jan 2016 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017 as reported by ClinicalTrials.gov record.
- 29 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.